Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Identical twins with a rare KRT 86 gene mutation both have the hair disorder monilethrix.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Key genes linked to wool quality in Spanish Merino sheep can improve fine wool production.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Policosanol biorefining shows promise for heart health, needing better academic-industrial collaboration.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

Metabolic processes and key genes like FGF5, FGFR1, and RRAS significantly affect hair follicle growth in Inner Mongolian Cashmere goats.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

The document emphasizes the importance of ongoing research and ethical considerations in genome editing and cellular reprogramming.

Tridax procumbens and Ouratea spectabilis can affect other plants' growth and have antioxidant benefits.

Giant axonal neuropathy changes the structure of keratin in human hair.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Microneedle delivery of a special collagen shows promise for treating hair loss.

Androgenetic alopecia causes hair thinning in women, affecting their quality of life.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

People with an imbalance between their cognitive and emotional empathy have lower levels of the hormone oxytocin in their hair.

NGF and minoxidil promote hair growth, while 17 beta-E2 inhibits it.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.